A Comparative Study To Determine If Motivating Asthma Education (Compliance Enhancement) Has An Effect On Asthma Control
Status:
Completed
Trial end date:
2007-06-13
Target enrollment:
Participant gender:
Summary
This study will investigate whether study subjects with previously uncontrolled asthma
treated with SERETIDE Diskus 50/250 CCI18781+GR33343 mcg twice a day can attain a level of
Total Control of their condition and whether adherence to treatment can be enhanced by
teaching the subjects. Two groups of equal size with identical medical treatment will be
compared with each other, the test group receiving three training modules during study visits
and the control group regular study visits only.
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Salmeterol Xinafoate Xhance